Alivus Life

{
  "main_header": {
    "sid": 1003513,
    "name": "Alivus Life",
    "stock_name": "Alivus Life",
    "full_name": "Alivus Life Sciences Ltd",
    "name_url": "stocks-analysis/alivus-life",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 1,
    "country_id": 34,
    "currency": "INR",
    "cmp": "1,041.80",
    "chg": 3.6,
    "chgp": "0.35%",
    "dir": 1,
    "prev_price": "1,038.20",
    "mcapval": "12,891.00 Cr",
    "mcap": "Small Cap",
    "scripcode": 543322,
    "symbol": "ALIVUS",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "India SENSEX",
    "isin": "INE03Q201024",
    "curr_date": "Apr 10",
    "curr_time": "",
    "bse_nse_vol": "56.03 k",
    "exc_status": "Active",
    "traded_date": "Apr 10, 2026",
    "traded_date_str": "2026 04 10",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/alivus-life-1003513-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Golden Cross Confirmed: Do Alivus Life Sciences Ltd's Other Technical Indicators Agree?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/alivus-life-sciences-ltd-forms-golden-cross-signalling-potential-bullish-breakout-3942046",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/AlivusLifeScien_goldencross_3942046.png",
        "date": "2026-04-10 18:00:37",
        "description": "The 50-day moving average has crossed above the 200-day moving average for Alivus Life Sciences Ltd, signalling a golden cross on 10 Apr 2026. While this technical event often suggests a shift towards bullish momentum, the broader technical and fundamental context presents a nuanced picture that merits closer examination."
      },
      {
        "title": "Alivus Life Sciences Ltd is Rated Hold",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/alivus-life-sciences-ltd-is-rated-hold-3937562",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/AlivusLifeScien_mojoScore_3937562.png",
        "date": "2026-04-08 10:10:03",
        "description": "Alivus Life Sciences Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 21 January 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 08 April 2026, providing investors with an up-to-date view of the company’s performance and outlook."
      },
      {
        "title": "Alivus Life Sciences Ltd Shows Technical Momentum Shift Amid Strong Returns",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/alivus-life-sciences-ltd-shows-technical-momentum-shift-amid-strong-returns-3936478",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/AlivusLifeScien_technicaldot_3936478.png",
        "date": "2026-04-08 08:03:55",
        "description": "Alivus Life Sciences Ltd has demonstrated a notable shift in technical momentum, moving from a mildly bearish stance to a mildly bullish outlook. This transition is supported by a combination of technical indicators including MACD, Bollinger Bands, and moving averages, signalling a potential uptrend for the pharmaceuticals and biotechnology small-cap stock."
      },
      {
        "title": "Why is Alivus Life Sciences Ltd falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-alivus-life-sciences-ltd-fallingrising-3936209",
        "imagepath": "",
        "date": "2026-04-08 01:33:36",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Robust Financial Performance Underpins Price Gains</strong></p>\n<p>Alivus Life Sciences has demonstrated impressive financial results in its latest quarterly report ending December 2025. The company recorded its highest-ever net sales at ₹672.89 crores, accompanied by a peak PBDIT of ₹231.28 crores. This translated into an operating profit margin of 34.37%, marking the strongest quarterly operating efficiency in its history. Such robust profitability metrics have reinforced investor confidence in the company’s operational capabilities and growth trajectory.</p>\n<p>Moreover, the company’s return on equity (ROE) stands at a healthy 18.73%, signalling effective management utilisation of shareholder funds. This level of ROE, combined with a zero average debt-to-equity ratio, highlights Alivus Li..."
      },
      {
        "title": "Alivus Life Sciences Ltd Technical Momentum Shifts Amid Mixed Indicator Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/alivus-life-sciences-ltd-technical-momentum-shifts-amid-mixed-indicator-signals-3935572",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/AlivusLifeScien_technicaldot_3935572.png",
        "date": "2026-04-07 08:05:39",
        "description": "Alivus Life Sciences Ltd has experienced a notable shift in its technical momentum, with recent indicators signalling a transition from a sideways trend to a mildly bearish stance. Despite a 3.08% gain on 7 April 2026, the stock’s technical parameters present a complex picture, reflecting both bullish and bearish signals across weekly and monthly timeframes."
      },
      {
        "title": "Alivus Life Sciences Ltd is Rated Hold",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/alivus-life-sciences-ltd-is-rated-hold-3921443",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/AlivusLifeScien_mojoScore_3921443.png",
        "date": "2026-03-28 10:10:27",
        "description": "Alivus Life Sciences Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 21 January 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 28 March 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and overall outlook."
      },
      {
        "title": "Alivus Life Sciences Ltd Technical Momentum Shifts Amid Mixed Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/alivus-life-sciences-ltd-technical-momentum-shifts-amid-mixed-market-signals-3909247",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/AlivusLifeScien_technicaldot_3909247.png",
        "date": "2026-03-24 08:04:48",
        "description": "Alivus Life Sciences Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical momentum, moving from a sideways trend to a mildly bearish stance. Despite a recent downgrade in daily moving averages and mixed monthly indicators, the stock’s weekly technicals suggest pockets of bullishness, reflecting a complex interplay of market forces as it navigates current price pressures."
      },
      {
        "title": "Alivus Life Sciences Gains 0.41%: 2 Key Factors Driving the Week",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/alivus-life-sciences-gains-041-2-key-factors-driving-the-week-3905115",
        "imagepath": "",
        "date": "2026-03-21 12:01:09",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>16 Mar:</strong> Valuation shifts to fair amid strong sector performance</p>\n                    <p><strong>17 Mar:</strong> Stock rebounds with 1.22% gain following valuation update</p>\n                    <p><strong>19 Mar:</strong> Technical momentum shifts signal mixed outlook</p>\n                    <p><strong>20 Mar:</strong> Stock closes week higher at Rs.948.90 (+2.37%)</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.925.70</div></div>\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-value\">Rs.94..."
      },
      {
        "title": "Alivus Life Sciences Ltd Technical Momentum Shifts Signal Mixed Outlook",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/alivus-life-sciences-ltd-technical-momentum-shifts-signal-mixed-outlook-3899758",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/AlivusLifeScien_technicaldot_3899758.png",
        "date": "2026-03-19 08:03:07",
        "description": "Alivus Life Sciences Ltd has experienced a notable shift in its technical momentum, moving from a mildly bearish stance to a more sideways trend. This transition is underscored by a complex interplay of technical indicators, including MACD, RSI, moving averages, and others, reflecting a nuanced outlook for investors in the Pharmaceuticals & Biotechnology sector."
      }
    ],
    "total": 270,
    "sid": "1003513",
    "stock_news_url": "https://www.marketsmojo.com/news/alivus-life-sciences-1003513"
  },
  "announcements": [
    {
      "caption": "Disclosure Under Regulation 30 Of SEBI (LODR) Regulations 2015",
      "datetime": "21-Mar-2026",
      "details": "Kindly refer attachment.",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
      "datetime": "12-Mar-2026",
      "details": "Disclosure under Regulation 30 of the SEBI (Listing Obligation and Disclosure Requirements) Regulations 2015 - Intimation of Investors/Analyst Meeting",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
      "datetime": "06-Mar-2026",
      "details": "Disclosure under Regulation 30 of SEBI (Listing Obligation and Disclosure Requirements) Regulations 2015 - Intimation of Investors/Analyst Meeting",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Alivus Life Sciences Ltd has declared <strong>250%</strong> dividend, ex-date: 01 Sep 25",
          "dt": "2025-09-01",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Golden Cross Confirmed: Do Alivus Life Sciences Ltd's Other Technical Indicators Agree?

2026-04-10 18:00:37

The 50-day moving average has crossed above the 200-day moving average for Alivus Life Sciences Ltd, signalling a golden cross on 10 Apr 2026. While this technical event often suggests a shift towards bullish momentum, the broader technical and fundamental context presents a nuanced picture that merits closer examination.

Read full news article

Alivus Life Sciences Ltd is Rated Hold

2026-04-08 10:10:03

Alivus Life Sciences Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 21 January 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 08 April 2026, providing investors with an up-to-date view of the company’s performance and outlook.

Read full news article

Alivus Life Sciences Ltd Shows Technical Momentum Shift Amid Strong Returns

2026-04-08 08:03:55

Alivus Life Sciences Ltd has demonstrated a notable shift in technical momentum, moving from a mildly bearish stance to a mildly bullish outlook. This transition is supported by a combination of technical indicators including MACD, Bollinger Bands, and moving averages, signalling a potential uptrend for the pharmaceuticals and biotechnology small-cap stock.

Read full news article

Why is Alivus Life Sciences Ltd falling/rising?

2026-04-08 01:33:36

Robust Financial Performance Underpins Price Gains

Alivus Life Sciences has demonstrated impressive financial results in its latest quarterly report ending December 2025. The company recorded its highest-ever net sales at ₹672.89 crores, accompanied by a peak PBDIT of ₹231.28 crores. This translated into an operating profit margin of 34.37%, marking the strongest quarterly operating efficiency in its history. Such robust profitability metrics have reinforced investor confidence in the company’s operational capabilities and growth trajectory.

Moreover, the company’s return on equity (ROE) stands at a healthy 18.73%, signalling effective management utilisation of shareholder funds. This level of ROE, combined with a zero average debt-to-equity ratio, highlights Alivus Li...

Read full news article

Alivus Life Sciences Ltd Technical Momentum Shifts Amid Mixed Indicator Signals

2026-04-07 08:05:39

Alivus Life Sciences Ltd has experienced a notable shift in its technical momentum, with recent indicators signalling a transition from a sideways trend to a mildly bearish stance. Despite a 3.08% gain on 7 April 2026, the stock’s technical parameters present a complex picture, reflecting both bullish and bearish signals across weekly and monthly timeframes.

Read full news article

Alivus Life Sciences Ltd is Rated Hold

2026-03-28 10:10:27

Alivus Life Sciences Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 21 January 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 28 March 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and overall outlook.

Read full news article

Alivus Life Sciences Ltd Technical Momentum Shifts Amid Mixed Market Signals

2026-03-24 08:04:48

Alivus Life Sciences Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical momentum, moving from a sideways trend to a mildly bearish stance. Despite a recent downgrade in daily moving averages and mixed monthly indicators, the stock’s weekly technicals suggest pockets of bullishness, reflecting a complex interplay of market forces as it navigates current price pressures.

Read full news article

Alivus Life Sciences Gains 0.41%: 2 Key Factors Driving the Week

2026-03-21 12:01:09

Key Events This Week

16 Mar: Valuation shifts to fair amid strong sector performance

17 Mar: Stock rebounds with 1.22% gain following valuation update

19 Mar: Technical momentum shifts signal mixed outlook

20 Mar: Stock closes week higher at Rs.948.90 (+2.37%)

Week Open

Rs.925.70

Week Close

Rs.94...

Read full news article

Alivus Life Sciences Ltd Technical Momentum Shifts Signal Mixed Outlook

2026-03-19 08:03:07

Alivus Life Sciences Ltd has experienced a notable shift in its technical momentum, moving from a mildly bearish stance to a more sideways trend. This transition is underscored by a complex interplay of technical indicators, including MACD, RSI, moving averages, and others, reflecting a nuanced outlook for investors in the Pharmaceuticals & Biotechnology sector.

Read full news article

View All News